Tag: Prostate cancer

Fusion Pharmaceuticals secures rights for advanced prostate cancer treatment from Heidelberg University and Euratom

businessnewstoday- February 18, 2024

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a trailblazer in the oncology sector specializing in the development of next-generation radiopharmaceuticals, has announced a landmark exclusive worldwide license ... Read More

Clarity Pharmaceuticals advances in SECuRE trial with promising prostate cancer treatment results

businessnewstoday- November 29, 2023

Clarity Pharmaceuticals (ASX: CU6), a clinical stage radiopharmaceutical company, announced significant progress in the SECuRE trial, marking a pivotal step in cancer treatment research. The ... Read More

Curium wraps up patient enrollment in ECLIPSE trial in prostate cancer

businessnewstoday- November 26, 2023

Curium, a leading figure in the global nuclear medicine sector, has proudly announced the successful completion of patient enrollment in the pivotal Phase 3 ECLIPSE ... Read More

Novartis gets Pluvicto EC approval for advanced prostate cancer

Raghuram Kadari- December 15, 2022

Novartis has received the approval of the European Commission (EC) for Pluvicto (lutetium (177Lu) vipivotide tetraxetan), a targeted radioligand therapy for advanced prostate cancer. Following ... Read More

Clinical-stage pharma firms Ayala Pharmaceuticals, Advaxis sign merger deal

businessnewstoday- October 22, 2022

Ayala Pharmaceuticals, a Nasdaq-listed clinical-stage oncology company, has entered into a merger deal with New Jersey-based biotech company Advaxis. Based in Delaware, Ayala Pharmaceuticals is ... Read More

Merck signs $290m deal with Orion Corporation for mCRPC candidate ODM-208

pallavi123- July 16, 2022

Merck has signed a global development and commercialization deal worth $290 million with Orion Corporation for the latter’s investigational candidate ODM-208 and other drugs that ... Read More

Liquid biopsy company ANGLE plc bags pharma services contract

pallavi123- April 17, 2021

UK-based liquid biopsy company ANGLE plc has won a pharma services contract worth up to $1.2 million from an undisclosed pharma company that is engaged ... Read More

Cancer Targeted Technology gets NIH grant to support CTT1403 trial

pharmanewsdaily- August 7, 2020

Cancer Targeted Technology (CTT), a Seattle-based biotech company, has secured a grant of $1.44 million from the US National Institutes of Health (NIH) to support ... Read More

Novartis wraps up $2.1bn acquisition of US biopharma company Endocyte

pallavi123- December 23, 2018

Pharma acquisition news : Swiss pharma giant Novartis has wrapped up its previously announced acquisition of US biopharma company Endocyte in a deal worth around ... Read More

US biopharma company Endocyte to be acquired by Novartis for $2.1bn

pallavi123- October 21, 2018

Novartis acquisition of Endocyte : US biopharma company Endocyte has agreed to be acquired by Swiss pharma company Novartis in a deal worth around $2.1 ... Read More